in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
103<br />
<strong>Cerep</strong><br />
services<br />
transporters<br />
Receptors<br />
❚ adenos<strong>in</strong>e<br />
adenos<strong>in</strong>e transporter - antagonist radioligand<br />
Source<br />
gu<strong>in</strong>ea-pig cerebral cortex<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ligand<br />
[ 3 H]NBTI (0.15 nM)<br />
Kd<br />
0.08 nM<br />
Ref. 0007<br />
Non specific NBTI (5 µM)<br />
Q 3 weeks<br />
Reference NBTI (IC 50 : 0.2 nM)<br />
Included <strong>in</strong>:<br />
Organ safety profile<br />
Verma, A. and Marangos, P.J. (1985) Life Sci., 36: 286-290.<br />
specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />
100<br />
50<br />
0<br />
-12 -11 -10 -9 -8 -7 -6 -5 -4<br />
log [drug] (M)<br />
NBTI<br />
dipyridamole<br />
CPA<br />
Ion<br />
channels<br />
<br />
Transporters<br />
adenos<strong>in</strong>e uptake<br />
cellul ar<br />
Ref. 3374<br />
Q 3 weeks<br />
Source<br />
Hela cells<br />
Tracer<br />
[ 3 H]2-8 adenos<strong>in</strong>e (0.1 µM)<br />
Measured product [ 3 H]2-8 adenos<strong>in</strong>e <strong>in</strong>corporation <strong>in</strong>to Hela<br />
cells<br />
Detection method sc<strong>in</strong>tillation count<strong>in</strong>g<br />
Reference<br />
❚ cannab<strong>in</strong>oid<br />
anandamide uptake<br />
cellul ar<br />
Ref. 0647<br />
Q 4 weeks<br />
❚ chol<strong>in</strong>e<br />
NBTI (IC 50 : 1.1 nM)<br />
Harley, E.R. et al.(1982) Cancer Res., 42: 1289-1295.<br />
Source<br />
U-937 cells<br />
Tracer<br />
[ 3 H]AEA (2 nM) + AEA (98 nM)<br />
Measured product [ 3 H]AEA <strong>in</strong>corporation <strong>in</strong>to U-937 cells<br />
Detection method sc<strong>in</strong>tillation count<strong>in</strong>g<br />
Reference<br />
AM 404 (IC 50 : 1 µM)<br />
Maccarrone, M. et al. (1998) J. Biol. Chem., 273: 32332-32339.<br />
chol<strong>in</strong>e transporter (CHT1) - antagonist radioligand<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Ref. 1552<br />
Q 3 weeks<br />
Included <strong>in</strong>:<br />
Diversity profile<br />
BioPr<strong>in</strong>t ® profile<br />
Organ safety profile<br />
Source<br />
Ligand<br />
Kd<br />
Non specific<br />
Reference<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
[ 3 H]hemichol<strong>in</strong>ium-3 (3 nM)<br />
3.9 nM<br />
hemichol<strong>in</strong>ium-3 (10 µM)<br />
hemichol<strong>in</strong>ium-3 (IC 50 : 14 nM)<br />
Apparsundaram, S. et al. (2000) Bioch. Biophys. Res. Com., 276: 862-867.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
❚ See other Adenos<strong>in</strong>e assays, page 13<br />
AEA uptake (% of control)<br />
100<br />
50<br />
0<br />
-9 -8 -7 -6 -5 -4<br />
log [drug] (M)<br />
AM 404<br />
AEA<br />
❚ See other Cannab<strong>in</strong>oid assays, page 27<br />
specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />
100<br />
50<br />
0<br />
-11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1<br />
log [drug] (M)<br />
hemichol<strong>in</strong>ium-3<br />
chol<strong>in</strong>e<br />
carbachol<br />
K<strong>in</strong>ases<br />
Epigenetic &<br />
DNA-related<br />
enzymes<br />
Other<br />
enzymes<br />
Specialized<br />
cellular<br />
assays<br />
Standard<br />
profiles<br />
Test<strong>in</strong>g<br />
conditions<br />
Order<strong>in</strong>g<br />
<strong>in</strong>formation<br />
Assay list<br />
& <strong>in</strong>dex